Skip to content
Clinical Trials – home

Bleomycin Sulfate: A Comprehensive Guide for Patients

2 / 6
trials open to patients / all trials
13+
Countries

In short

Bleomycin sulfate, a powerful antineoplastic drug, is being studied in various clinical trials to explore its potential in treating different medical conditions. These trials aim to evaluate the efficacy and safety of bleomycin sulfate in treating cutaneous warts, venous malformations, lymphatic malformations, and as part of combination therapies for cancers like Hodgkin's lymphoma and Kaposi's sarcoma. The research focuses on optimizing dosages, comparing bleomycin to other treatments, and investigating its use in combination with other drugs to improve patient outcomes.

What is Bleomycin?

Bleomycin sulfate, often simply called bleomycin, is an anticancer drug derived from the bacterium Streptomycus verticillus. It's also known by other names such as Bleomycin Baxter, Zeocin, and Blenoxane. Bleomycin works by damaging the DNA in cells, which can stop cancer cells from growing and dividing.

Uses of Bleomycin

Bleomycin is used to treat various conditions:

  • Cancer treatment: It's used in the treatment of several types of cancer, including lymphoma and testicular cancer.
  • Vascular anomalies: Bleomycin is used to treat various types of vascular (blood vessel) abnormalities:
    • Venous malformations: These are abnormal clusters of blood vessels.
    • Lymphatic malformations: These are fluid-filled spaces caused by abnormal development of lymphatic vessels.
    • Infantile hemangiomas: These are benign (non-cancerous) growths of blood vessels that appear in infants.
  • Skin conditions: Bleomycin is used to treat various skin conditions:
    • Cutaneous warts: These are small, rough growths on the skin caused by a virus.
    • Keloid and hypertrophic scars: These are types of raised scars that can occur after injury to the skin.
  • Kaposi's sarcoma: This is a type of cancer that causes patches of abnormal tissue to grow under the skin, in the lining of the mouth, nose, and throat, or in other organs.

How Bleomycin is Administered

Bleomycin can be given in several ways, depending on the condition being treated:

  • Intravenous (IV) injection: The drug is injected directly into a vein. This is often used for cancer treatment.
  • Intralesional injection: The drug is injected directly into the abnormal tissue. This is often used for vascular malformations and skin conditions.
  • Sclerotherapy: This is a procedure where bleomycin is injected into blood vessels to shrink them. It's often used for vascular malformations.
  • Electrochemotherapy: This is a technique where bleomycin is given intravenously, and then electric pulses are applied to the tumor area. This helps the bleomycin enter the cancer cells more effectively.

Efficacy of Bleomycin

The effectiveness of bleomycin varies depending on the condition being treated:

  • Cancer: Bleomycin has been shown to be effective against certain types of cancer, particularly when used in combination with other drugs.
  • Vascular malformations: Studies have shown that bleomycin can be effective in reducing the size of various types of vascular malformations.
  • Skin conditions: Bleomycin has shown promising results in treating warts and certain types of scars.

Potential Side Effects

Like all medications, bleomycin can cause side effects. Some potential side effects include:

  • Skin reactions: About half of patients may experience skin-related side effects such as redness, skin soreness, or changes in skin color.
  • Lung problems: In rare cases (about 1% of patients), bleomycin can cause serious lung problems, including a condition called pulmonary fibrosis.
  • Other side effects: These may include fever, loss of appetite, and fatigue.

The risk of side effects may increase with higher doses and in older patients.

Ongoing Research

Researchers are continually studying bleomycin to improve its use and effectiveness:

  • Dose optimization: Studies are investigating whether lower doses of bleomycin can be as effective as standard doses while reducing side effects.
  • Combination therapies: Researchers are studying how bleomycin works when combined with other treatments, such as dexamethasone for infantile hemangiomas.
  • New applications: Scientists are exploring the use of bleomycin for conditions it hasn't traditionally been used to treat.

It's important to note that while bleomycin is a powerful and useful drug, it should only be used under the close supervision of a healthcare professional. Your doctor will weigh the potential benefits against the risks for your specific situation.

Questions people often ask

Conditions where Bleomycin Sulfate is being studied

Each condition opens its own overview and trial list

Trials with Bleomycin Sulfate

Recruiting trials first

See all 6 →
Quick filters
  • Participants:All ages
  • Participants:Adults
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).